Innate immunology in COVID-19 - a living review. Part II: dysregulated inflammation drives immunopathology
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome...
Main Authors: | Rodrigues, PRS, Alrubayyi, A, Pring, E, Bart, VMT, Jones, R, Coveney, C, Lu, F, Tellier, M, Maleki-Toyserkani, S, Richter, FC, Scourfield, DO, Gea-Mallorquí, E, Davies, LC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2020
|
Similar Items
-
Innate immunology in COVID-19 – a living review. Part I: viral entry, sensing and evasion
by: Coveney, C, et al.
Published: (2020) -
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
by: Codd, AS, et al.
Published: (2021) -
An introduction to immunology and immunopathology
by: Jean S. Marshall, et al.
Published: (2018-09-01) -
The role and uses of antibodies in COVID-19 infections: a living review
by: Scourfield, DO, et al.
Published: (2021) -
Proceedings, of the round table on immunology and immunopathology
by: Cláudio Tadeu Daniel Ribeiro
Published: (1986-01-01)